NEMOTORNYE SIMPTOMY TsERVIKAL'NOY DISTONII

T Yu Avseytseva; A F Ivolgin

Bulletin of the Russian Military Medical Academy ›› 2018, Vol. 20 ›› Issue (3S) : 10 -13.

Articles

research-article

NEMOTORNYE SIMPTOMY TsERVIKAL'NOY DISTONII

Author information +

History +

Abstract

Cite this article

Download citation ▾

T Yu Avseytseva, A F Ivolgin. NEMOTORNYE SIMPTOMY TsERVIKAL'NOY DISTONII. Bulletin of the Russian Military Medical Academy, 2018, 20(3S): 10-13 DOI:

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Jankovic J, Treatment of dystonia, Lancet Neurol, 2006;5:864-72.

[2]	Chan J, Idiopathic cervical dystonia: clinical characteristics, / Chan J, Brin MF, Fahn S, // Mov Disord, 1991;6:119-26.

[3]	Epidemiologic Study of Dystonia in Europe (ESDE) Collaborative Group, A prevalence study of primary dystonia in eight European countries, J Neurol, 2000;247:787-92.

[4]	Jahanshahi M, Factors that ameliorate or aggravate spasmodic torticollis, J Neurol Neurosurg Psychiatry, 2000;68:227-9.

[5]	Marie-Helene Marion, British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor re- sponse to botulinum toxin / Marie-Helene Marion, Miles Humberstone, Richard Grunewald, Sunil Wimalaratna

[6]	H. A. Jinnah, for the Dystonia Coalition Investigators: Longitudinal Studies of Botulinum Toxin in Cervical Dystonia: Why Do Patients Discontinue Therapy? / H. A. Jinnah, Cynthia L Comella, Joel Perlmutter, Codrin Lungu, Mark Hallett // Toxicon. 2018 Jun 1; 147: 89-95.

[7]	Miguel Coelho, Pain and Quality of Life in the Treatment of Cervical Dystonia / Miguel Coelho, Anabela Ferreira Valadas, Tiago Mestre, Joaquim J Ferreira

[8]	Kutvonen O, Pain in spasmodic torticollis / Kutvonen O, Dastidar P, Nurmikko T // Pain, 1997;69:279-86.

[9]	Lobbezoo F, Pain perception in idiopathic cervical dystonia (spasmodic torticollis) / Lobbezoo F, Tanguay R, Thon MT, Lavigne GJ // Pain, 1996;67:483-91.

[10]	Konrad C, Orthopedic and neurological complications of cervical dystonia - review of the literature / Konrad C, Vollmer-Haase J, Anneken K, Knecht S // Acta Neurol Scand, 2004;109:369-73.

[11]	Tonomura Y, Atlantoaxial rotatory subluxation associated with cervical dystonia / Tonomura Y, Kataoka H, Sugie K, et al. // Spine (Phila Pa 1976), 2007;32:E561-4.

[12]	Camfield L, Impact of cervical dystonia on quality of life / Camfield L, Ben-Shlomo Y, Warner TT // Mov Disord, 2002;17:838-41.

[13]	Hilker R, Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia / Hilker R, Schischniaschvili M, Ghaemi M, et al. // J Neurol Neurosurg Psychiatry, 2001;71:193-9.

[14]	Skogseid IM, Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia / Skogseid IM, Malt UF, Roislien J, Kerty E // Eur J Neurol, 2007;14: 1129-37.

[15]	Cano SJ, Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58) / Cano SJ, Warner TT, Linacre JM, et al. // Neurology, 2004;63:1629-33.

[16]	Simpson DM, Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology / Simpson DM, Blitzer A, Brashear A, et al. // Neurology, 2008;70:1699-1706.

[17]	орлова о.Р. опыт применения нового ботулинического токсина типа А Релатокс в клинической практике / орлова о.Р., Коновалова З.Н., Мингазова Л.Р., Саксонова е.В., Сойхер М.И., Щелокова е.Б. // Вестник МооСБт. Метаморфозы. 2014; 8 (но- ябрь): 2-4.

[18]	Латышева Н.В. Головная боль в практике врача-косметолога / Латышева Н.В., орлова о.Р. // Вестник МооСБт. Метамор- фозы. 2017; 18: 81-86.